Finance

UK-based medical device company seeks $4 billion in sale, FT reports

Published by Global Banking & Finance Review

Posted on June 3, 2025

1 min read

· Last updated: January 23, 2026

Add as preferred source on Google
Norway's sovereign fund logo reflecting divestment from Israeli stocks amid Gaza conflict - Global Banking & Finance Review
The image depicts the logo of Norway's Sovereign Fund, which plans to divest from Israeli companies due to the ongoing humanitarian crisis in Gaza. This decision reflects ethical investment practices and highlights the fund's significant influence in global finance.
Global Banking & Finance Awards 2026 — Call for Entries

(Reuters) -UK-based medical device company CMR Surgical has put itself up for sale at a valuation of up to $4 billion, the Financial Times reported on Tuesday, citing sources familiar with the matter.

UK-based medical device company seeks $4 billion in sale, FT reports

(Reuters) -UK-based medical device company CMR Surgical has put itself up for sale at a valuation of up to $4 billion, the Financial Times reported on Tuesday, citing sources familiar with the matter.

The surgical robotics maker had hired advisers in recent weeks to initiate the sale process, likely to elicit interest from large strategic buyers, the report added.

Founded in 2014, CMR Surgical received U.S. Food and Drug Administration approval for the upgraded version of its flagship Versius surgical robot in October last year, to be used in gall bladder removal procedures.

Reuters could not immediately verify the report. CMR Surgical did not immediately respond to a request for comment outside regular business hours.

(Reporting by Ananya Palyekar in Bengaluru; Editing by Sonia Cheema)

Key Takeaways

  • CMR Surgical is seeking a $4 billion sale.
  • The company specializes in surgical robotics.
  • Advisers have been hired to manage the sale process.
  • The Versius surgical robot is FDA approved.
  • Potential interest from large strategic buyers.

Frequently Asked Questions

What is the valuation CMR Surgical is seeking?
CMR Surgical has put itself up for sale at a valuation of up to $4 billion.
When did CMR Surgical receive FDA approval for its robot?
CMR Surgical received U.S. Food and Drug Administration approval for the upgraded version of its Versius surgical robot in October last year.
What type of buyers is CMR Surgical targeting for its sale?
The company is likely to elicit interest from large strategic buyers as it initiates the sale process.
Who reported on CMR Surgical's sale process?
The Financial Times reported on CMR Surgical's sale process, citing sources familiar with the matter.
Did CMR Surgical respond to the report about its sale?
CMR Surgical did not immediately respond to a request for comment outside regular business hours.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category